Direct 99mTc labeling of Herceptin (trastuzumab) by 99mTc(I) tricarbonyl ion

This publication has 9 references indexed in Scilit:

• Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [99mTc]-HYNIC-trastuzumab (Herceptin) Fab fragments
  Nuclear Medicine Communications, 2005
• Radiobromination of anti-HER2/neu/ErbB-2 monoclonal antibody using the p-isothiocyanatobenzene derivative of the [76Br]undecahydro-bromo-7,8-dicarba-nido-undecaborate(1-) ion
  Nuclear Medicine and Biology, 2004
• Labeling anti-HER2/neu Monoclonal Antibodies with ¹¹¹In and ⁹⁰Y Using a Bifunctional DTPA Chelating Agent
  Cancer Biotherapy & Radiopharmaceuticals, 2003
• Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
  Nature, 2003
• A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin™
  Nuclear Medicine and Biology, 2002
• HER‐2/neu is overexpressed infrequently in patients with prostate carcinoma
  Cancer, 2002
• The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker
  European Journal Of Cancer, 2001
• A Novel Organometallic Aqua Complex of Technetium for the Labeling of Biomolecules: Synthesis of [^99mTc(OH₂)₃(CO)₃]⁺ from [^99mTcO₄]^- in Aqueous Solution and Its Reaction with a Bifunctional Ligand
  Journal of the American Chemical Society, 1998
• Labeling of human serum albumin with 105Rhcysteine complexes
  International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1990